4.7 Article

A novel minicircle vector based system for inhibting the replication and gene expression of Enterovirus 71 and Coxsackievirus A16

期刊

ANTIVIRAL RESEARCH
卷 96, 期 2, 页码 234-244

出版社

ELSEVIER
DOI: 10.1016/j.antiviral.2012.08.003

关键词

Enterovirus 71; Coxsackievirus A16; Minicircle vector; RNA interference; Antiviral therapy

资金

  1. National Basic Research Program of China (973 Program) [2011CB504703, 2010CB530102]
  2. Major National Science & Technology Specific Projects of China [2009ZX09103-747]
  3. National Science Foundation of China (NSFC) [81021003]

向作者/读者索取更多资源

Enterovirus 71 (EV 71) and Coxsackievirus A16 (CA 16) are two major causative agents of hand, foot and mouth disease (HFMD). They have been associated with severe neurological and cardiological complications worldwide, and have caused significant mortalities during large-scale outbreaks in China. Currently, there are no effective treatments against EV 71 and CA 16 infections. We now describe the development of a novel minicircle vector based RNA interference (RNAi) system as a therapeutic approach to inhibiting EV 71 and CA 16 replication. Small interfering RNA (siRNA) molecules targeting the conserved regions of the 3C(pro) and 3D(pol) function gene of the EV 71 and CA 16 China strains were designed based on their nucleotide sequences available in GenBank. This RNAi system was found to effectively block the replication and gene expression of these viruses in rhabdomyosarcoma (RD) cells and virus-infected mice model. The inhibitory effects were confirmed by a corresponding decrease in viral RNA, viral protein, and progeny virus production. In addition, no significant adverse off-target silencing or cytotoxic effects were observed. These results demonstrated the potential and feasibility of this novel minicircle vector based RNAi system for antiviral therapy against EV 71 and CA 16 infection. (C) 2012 Elsevier BM. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据